Abattis Bioceuticals Corp. | Balance Sheet
Fiscal year is October-September. All values CAD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
5.30
1,359.30
257.50
38.50
525.60
Total Accounts Receivable
26.80
152.70
39.30
38.70
128.20
Other Current Assets
39.80
60.90
52.30
13.40
25.40
Total Current Assets
71.90
1,572.90
349.10
90.60
679.20
Net Property, Plant & Equipment
481.30
793.00
166.10
148.90
529.60
Total Investments and Advances
-
471.20
-
-
-
Intangible Assets
1,074.20
3,064.70
1,096.40
1,026.10
-
Other Assets
2.00
2.00
2.00
2.00
2.00
Total Assets
1,629.30
5,903.80
1,613.60
1,267.50
1,210.90
ST Debt & Current Portion LT Debt
290.20
-
-
-
-
Accounts Payable
239.00
317.50
717.30
608.20
-
Other Current Liabilities
542.20
559.60
419.70
418.70
439.40
Total Current Liabilities
1,071.30
877.10
1,137.00
1,026.80
439.40
Long-Term Debt
-
-
-
30.90
-
Deferred Taxes
-
383.70
-
-
-
Total Liabilities
1,071.30
1,260.80
1,137.00
1,057.80
439.40
Common Equity (Total)
558.00
4,043.20
860.60
671.00
1,524.70
Total Shareholders' Equity
558.00
4,043.20
860.60
671.00
1,524.70
Total Equity
558.00
4,643.00
476.70
209.80
771.50
Liabilities & Shareholders' Equity
1,629.30
5,903.80
1,613.60
1,267.50
1,210.90
Accumulated Minority Interest
-
599.80
383.90
461.20
753.20
About Abattis Bioceuticals
View Profile
